mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile

Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex

(2022) Lena H. Nguyen et al.   EPILEPSY RESEARCH

Sex-Specific Alterations in Inflammatory MicroRNAs in Mouse Brain and Bone Marrow CD11b+ Cells Following Traumatic Brain Injury

(2021) Paresh Prajapati et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

A multistep approach to the genotype-phenotype analysis of Polish patients with tuberous sclerosis complex

(2021) Katarzyna Bąbol-Pokora et al.   European Journal of Medical Genetics

NormiRazor: tool applying GPU-accelerated computing for determination of internal references in microRNA transcription studies

(2020) Szymon Grabia et al.   BMC BIOINFORMATICS

The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas

(2019) Anika Bongaarts et al.   BRAIN

Licochalcone A restrains microphthalmia‐associated transcription factor expression and growth by activating autophagy in melanoma cells via miR‐142‐3p/Rheb/mTOR pathway

(2019) Yuhong Zhang et al.   PHYTOTHERAPY RESEARCH

miRWalk: An online resource for prediction of microRNA binding sites

(2018) Carsten Sticht et al.   PLoS One

LncRNA SNHG14 promotes inflammatory response induced by cerebral ischemia/reperfusion injury through regulating miR-136-5p /ROCK1

(2018) Yu Zhong et al.   CANCER GENE THERAPY

The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma

(2017) John J. Bissler et al.   PEDIATRIC NEPHROLOGY

Analysis of miRNAs Involved in Mouse Brain Damage upon Enterovirus 71 Infection

(2017) Xiaoxia Yang et al.   Frontiers in Cellular and Infection Microbiology

MicroRNA abundance is altered in synaptoneurosomes during prion disease

(2016) Amrit S. Boese et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Differential Expression and Significance of Circulating microRNAs in Cerebrospinal Fluid of Acute Encephalitis Patients Infected with Japanese Encephalitis Virus

(2016) Saptamita Goswami et al.   MOLECULAR NEUROBIOLOGY

Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications

(2016) Joanna Trelinska et al.   Orphanet Journal of Rare Diseases

Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study

(2016) David N. Franz et al.   PLoS One

Genotype/Phenotype Correlations in Tuberous Sclerosis Complex

(2015) Paolo Curatolo et al.   Seminars in Pediatric Neurology

Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

(2013) Hope Northrup et al.   PEDIATRIC NEUROLOGY

Tailoring mTOR-based therapy: molecular evidence and clinical challenges

(2013) Gaetano Santulli et al.   PHARMACOGENOMICS

MicroRNAs in Stress Signaling and Human Disease

(2012) Joshua T. Mendell et al.   CELL

Assessing sample and miRNA profile quality in serum and plasma or other biofluids

(2012) Thorarinn Blondal et al.   METHODS

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

(2011) Michelle C. Mendoza et al.   TRENDS IN BIOCHEMICAL SCIENCES

Novel Proteins Regulated by mTOR in Subependymal Giant Cell Astrocytomas of Patients with Tuberous Sclerosis Complex and New Therapeutic Implications

(2010) Magdalena Ewa Tyburczy et al.   AMERICAN JOURNAL OF PATHOLOGY

Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model

(2009) Ruifang Mi et al.   Journal of Genetics and Genomics

The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

(2008) Jingxiang Huang et al.   BIOCHEMICAL JOURNAL

Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis

(2008) John J. Bissler et al.   NEW ENGLAND JOURNAL OF MEDICINE